Eupraxia Pharmaceuticals Inc.
OTC: EPRXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James A. Helliwell FRCPC,
- Employees
- 21
- Headquarters
- Victoria, Canada
- IPO year
- 2021
- Market cap
- $108.3M
- Website
- https://www.eupraxiapharma.com
Loading EPRXF…
Loading profile data…Frequently asked questions about EPRXF
What does Eupraxia Pharmaceuticals Inc. (EPRXF) do?
Eupraxia Pharmaceuticals Inc. operates as a clinical-stage biotechnology firm, focusing its efforts on the discovery, advancement, and commercialization of innovative technologies within the biotech landscape. The company's leading therapeutic compound, EP-104IAR, is currently progressing through Phase II clinical trials. This candidate is desig...
Where does EPRXF trade?
Eupraxia Pharmaceuticals Inc. (EPRXF) trades on the Other OTC.
What sector is EPRXF in?
Eupraxia Pharmaceuticals Inc. (EPRXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Eupraxia Pharmaceuticals Inc.?
James A. Helliwell FRCPC, is the chief executive officer of Eupraxia Pharmaceuticals Inc. (EPRXF).
Where is Eupraxia Pharmaceuticals Inc. headquartered?
Eupraxia Pharmaceuticals Inc. is headquartered in Canada.
Does EPRXF pay a dividend?
Eupraxia Pharmaceuticals Inc. (EPRXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EPRXF go public?
Eupraxia Pharmaceuticals Inc. (EPRXF) completed its initial public offering in 2021.